Urogenital fistula reviewed: a marker of severe maternal morbidity and an indicator of the quality of maternal healthcare delivery.
Urogenital fistula reviewed: a marker of severe maternal morbidity and an indicator of the quality of maternal healthcare delivery.
复制标题
DOI：
10.1186/s40748-015-0020-7
复制
发表时间：
2015
期刊：
影响因子：
--
通讯作者：
McClure EM
中科院分区：
文献类型：
--
作者：
Harrison MS;Mabeya H;Goldenberg RL;McClure EM
虽然产科瘘管病自1980年代以来一直被认为是一种主要的孕产妇发病率，但它已成为衡量妇女获得保健的机会和保健质量的一个指标。低收入国家仍然存在产科瘘管病，因为保健系统未能提供适当的计划生育、熟练的助产护理、基本和紧急产科护理以及负担得起的瘘管病治疗，同时缺乏社交网络作为受影响女孩和妇女的安全网[世卫组织，2007年]。本综述探讨了最近发表的关于瘘管病定义、诊断、治疗和管理的经验，以及在全球范围内预防瘘管病的进一步措施。
While obstetric fistula has been recognized as a major maternal morbidity since the 1980s, it has become an indicator of access to and quality of women’ s health care. Obstetric fistula still exists in low-income countries (LIC) because health care systems fail to provide adequate family planning, skilled birth attendance, basic and emergency obstetric care, and affordable treatment of fistula, while concurrently lacking social networks to serve as safety nets for affected girls and women [WHO, 2007]. This review explores the most recent published experience with respect to the definition of fistula, its diagnosis, treatment, and management, and further steps for prevention of fistula on a global scale.